Kaplan-Meier Curves, Cox Model, and P-Values Are Not Enough for the Prognostic Evaluation of Tumor Markers: Statistical Suggestions for a More Comprehensive …

P Boracchi, P Roccabianca, G Avallone… - Veterinary …, 2021 - journals.sagepub.com
The assessment of prognostic markers is key to the improvement of therapeutic strategies for
cancer patients. Some promising markers may fail to be applied in clinical practice, or some …

Prognostic and predictive markers in canine tumours: rationale and relevance. A review

S Mukaratirwa - Veterinary Quarterly, 2005 - Taylor & Francis
Cancer is one of the most common causes of death in dogs. The availability of multiple
treatment modalities and novel therapeutic targets make the correct diagnosis, prognostic …

Handling cause of death in equivocal cases using the EM algorithm

RL Kodell, JJ Chen - Communications in Statistics-Theory and …, 1987 - Taylor & Francis
The statistical analysis of animal bioassays fore carcinogenicity often involves utilizing the
cause of death of each animal. There is considerable disagreement among veterinary …

Serum biomarker profiling in cancer studies: a question of standardisation?

B Matharoo‐Ball, AK Miles, CS Creaser… - Veterinary and …, 2008 - Wiley Online Library
Companion animals are exposed to similar environmental conditions and carcinogens as
humans. In some animal cancers, there also appears to be the same genetic changes …

Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology

JD Webster, MM Dennis, N Dervisis… - Veterinary …, 2011 - journals.sagepub.com
There is an increasing need for more accurate prognostic and predictive markers in
veterinary oncology because of an increasing number of treatment options, the increased …

Clinical techniques in small animal molecular oncology

PJ Bergman - Clinical techniques in small animal practice, 2003 - Elsevier
The diagnosis, staging, and treatment of tumors in veterinary as well as human oncology
have traditionally incorporated elements of anatomic extent of neoplasia through various …

Markers of prognosis and response to treatment: ready for clinical use in oncology? A biostatistician's viewpoint

P Boracchi, E Biganzoli - The International Journal of …, 2003 - journals.sagepub.com
Cancer is a heterogeneous disease: tumors are highly variable in their growth rates,
patterns of metastases and other biological characteristics. The benefit derived from any …

Standardized tumor rates for chronic bioassays

RL Kodell, DW Gaylor, JJ Chen - Biometrics, 1986 - JSTOR
If crude experimental proportions of animals with tumor from chronic bioassays for
carcinogenicity are used for low-dose extrapolation in a risk analysis, different dose-specific …

[HTML][HTML] Classification and grading of canine malignant mammary tumors

A Tavasoly, H Golshahi, A Rezaie… - … research forum: an …, 2013 - ncbi.nlm.nih.gov
Histological grading is a good parameter to stratify tumors according to their biological
aggressiveness. The Elston and Ellis grading method in humans, invasive ductal breast …

Biostatistics and tumor marker studies in breast cancer: design, analysis and interpretation issues

E Biganzoli, P Boracchi… - The International Journal …, 2003 - journals.sagepub.com
The development of staging procedures for breast cancer aimed at the identification of
distinct, homogeneous patient categories with different chances of benefiting from treatment …